Australian (ASX) Stock Market Forum

CU6 - Clarity Pharmaceuticals

In 12 months the price has risen about 330% and then fallen about 400% to now be lower than a year ago.
@RealCountryLad

you seem to have picked up a shadow

Screenshot_20250404_091129_Chrome~2.jpg
 
$1.68 ...down from $8+ only six months ago

Clarity receives $11.1 million R&D Tax Incentive refund.
Over $100 million in funding and refocus on high-priority programs.

HIGHLIGHTS
• Clarity received an $11,146,204 Research and Development Tax Incentive refund, inclusive of interest, as part of the Australian Federal Government’s R &D Tax Incentive program.
• The receipt of the $11.1 million will provide additional funding to further the development of Clarity’s Targeted Copper Theranostic platform of products for various cancer indications .
• Clarity is well funded with approximately $106 million in cash, the majority of which will be spent directly on research, development and commercialisation endeavours in the Company’s key programs .
• Following a thorough review of Clarity’s portfolio of clinical-stage assets as well as an in-depth analysis of the markets and their potential risks, the Company will prioritise the development of 64/67Cu-SAR-bisPSMA for both diagnostic and therapeutic applications in prostate cancer as well as the development of 64Cu-SARTATE in neuroendocrine tumours (NETs) and 64Cu-SAR-Bombesin in breast and prostate cancers.
• Clarity will also continue to progress its Discovery Program, aiming to bring key asets such as 64Cu-SAR -bisFAP and 64/67Cu-SAR -trastuzumab to the clinic.
• As part of this priortitisation process, the CL04 trial with 64/67Cu-SARTATE in paediatric high-risk neuroblastoma and the COMBAT trial with 64/67Cu-SAR -Bombesin in low prostate-specific membrane antigen (PSMA) metastatic castration-resistant prostate cancer (mCR P C) will be closed.
 
$1.68 ...down from $8+ only six months ago
but closed at $1.90..

Clarity signs high-volume commercial-scale copper-64 Supply Agreement

Highlights
• Clarity has signed a commercial-scale agreement with Nusano, Inc. for supply of copper-64 (Cu-64 or 64Cu) isotope.
• The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more than 1,000 Ci (37,000 GBq) of copper-64 per day at capacity, which translates into more than 18,000 patient doses per day at 200 MBq per dose, with a 48-hour shelf-life, far in excess of commercial scale demands across multiple large indications.
• The copper-64 supply from Nusano will complement Clarity’s existing network of US-based suppliers to ensure seamless, abundant production of this diagnostic isotope as the Company is progressing a number of late-stage clinical trials and fast approaching commercialisation.
• Nusano plans to begin production of other medical isotopes, such as copper-67 and actinium-225, both of which are used in Clarity’s products, in 2025-2026.
 
a steady retracement as per my cunning plan to stand out in the CY2025 tipping comp @mullokintyre

has been as low as $1.43 but April has seen announcements ^^ and a bit of interest
Screenshot_20250425_105423_CommSec~2.jpg
 
has been as low as $1.43 but April has seen announcements ^^ and a bit of interest
$2.22

At the ARG investment seminar, last week, there were questions from the floor after the presentations.

Q. (paraphrasing) "Last year your analyst mentioned CU6 as a stock of interest when it was under $4. I bought some and it went to more than $8 but now is close to $2. Any comments?"
Reply : "Did you sell any?"

@mullokintyre for the yearly Comp.
 
At the ARG investment seminar, last week, there were questions from the floor after the presentations.

Q. (paraphrasing) "Last year your analyst mentioned CU6 as a stock of interest when it was under $4. I bought some and it went to more than $8 but now is close to $2. Any comments?"
Reply : "Did you sell any?"
I was at that meeting.

I thought it was you asking the question @Dona Ferentes ! :)
 
Clarity Pharmaceuticals (CU6) +12.02% is one step closer to U.S FDA approval after promising results in Phase II clinical trials data, with the cancer-detecting copper-isotope drug now progressing to final Phase III testing.
 
This month's post for the yearly Comp @mullokintyre

Travelling sideways, some announcements of note but not moving the dial
- enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- SABRE topline results: 64Cu-SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
- DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway
Screenshot_20250625_154603_CommSec~2.jpg
 
This month's post for the yearly Comp @mullokintyre
seems to have picked up this month ,
Screenshot_20250727_103035_CommSec~2.jpg

Have recruited for a trial,
A director - at $937,500 exercise price – exercise of options on a cashless basis applying a share price of $2.2999 being the 5 day VWAP prior to instruction to exercise. (tweasy)
Quarterly out soon
 
$4.22

Highlights
• Clarity has successfully completed a $203 million Placement with a small group of institutional investors who are close to the Company.
• The issue price of the Placement is $4.20 per share, which represents a 2.2% premium to Clarity’s previous closing price and an 18.0% premium to Clarity’s 15-day Volume Weighted Average Price.
• Following completion of the Placement, the pro-forma cash balance of the Company is approximately $288 million, providing Clarity with an enviable Balance Sheet. This will help fund the below-mentioned expected catalysts and milestones, including the completion of a number of high-value pivotal clinical trials and advancement of key milestones in its therapeutic and diagnostic pipeline.
 
Heavily shorted stock. Was amonst the top 10 most shorted stock a week ago. Expect volitivity.

Top shorted stocks​


This is a list of the top 100 shorted stocks on the ASX by aggregate percentage shorted, along with their weekly change. Data sourced from ASIC. Download the full list in CSV format here.
1BOEBOSS ENERGY LTD ORDINARY21.23%1.56
2PDNPALADIN ENERGY LTD ORDINARY18.21%0.41
3PLSPILBARA MIN LTD ORDINARY15.32%0.65
4SLXSILEX SYSTEMS ORDINARY13.36%1.78
5IELIDP EDUCATION LTD ORDINARY13.26%0.76
6LICLIFESTYLE COMMUNIT. ORDINARY11.72%0.03
7PNVPOLYNOVO LIMITED ORDINARY11.71%0.15
8MINMINERAL RESOURCES. ORDINARY11.55%1.48
9CTDCORP TRAVEL LIMITED ORDINARY9.80%0.22
10ILUILUKA RESOURCES ORDINARY9.02%2.28
11LTRLIONTOWN RESOURCES ORDINARY8.51%4.73
12PWHPWR HOLDINGS LIMITED ORDINARY8.45%0.31
13CTTCETTIRE ORDINARY8.37%0.24
14DYLDEEP YELLOW LIMITED ORDINARY8.25%0.16
15NANNANOSONICS LIMITED ORDINARY7.76%0.30
16BGLBELLEVUE GOLD LTD ORDINARY7.73%0.12
17GYGGUZMAN Y GOMEZ LTD ORDINARY7.71%1.01
18KARKAROON ENERGY LTD ORDINARY7.55%0.22
19LOTLOTUS RESOURCES LTD ORDINARY7.47%0.69
20NXTNEXTDC LIMITED ORDINARY7.32%0.24
21DMPDOMINO PIZZA ENTERPR ORDINARY6.84%0.86
22SGRTHE STAR ENT GRP ORDINARY6.71%0.65
23CU6CLARITY PHARMA ORDINARY6.31%0.63
24BRGBREVILLE GROUP LTD ORDINARY6.12%0.23
25VEAVIVA ENERGY GROUP ORDINARY6.02%0.17
26RIORIO TINTO LIMITED ORDINARY5.88%0.27
27MSBMESOBLAST LIMITED ORDINARY5.75%0.05
28VULVULCAN ENERGY ORDINARY5.68%0.84
29HLSHEALIUS ORDINARY5.57%0.66
30APXAPPEN LIMITED ORDINARY5.56%0.11
31FLTFLIGHT CENTRE TRAVEL ORDINARY5.51%0.01
32CUVCLINUVEL PHARMACEUT. ORDINARY5.43%0.08
33IGOIGO LIMITED ORDINARY5.39%1.27
34GMDGENESIS MINERALS ORDINARY5.30%0.01
35ELDELDERS LIMITED ORDINARY5.28%0.32
36PENPENINSULA ENERGY LTD ORDINARY5.19%0.00
37NVXNOVONIX LIMITED ORDINARY5.07%0.50
38TLXTELIX PHARMACEUTICAL ORDINARY5.05%0.10
39CIACHAMPION IRON LTD ORDINARY5.04%0.29
40BMNBANNERMAN ENERGY LTD ORDINARY5.01%1.20
41NEUNEUREN PHARMACEUT. ORDINARY4.90%0.17
42MVFMONASH IVF GROUP LTD ORDINARY4.89%0.36
43STXSTRIKE ENERGY LTD ORDINARY4.73%0.17
44IPXIPERIONX LIMITED ORDINARY4.73%0.17
45ARBARB CORPORATION. ORDINARY4.61%0.04
46RFFRURAL FUNDS GROUP UNITS STAPLED4.52%0.02
47PTMPLATINUM ASSET ORDINARY4.50%0.13
48NCKNICK SCALI LIMITED ORDINARY4.47%0.55
49AD8AUDINATEGROUPLTD ORDINARY4.47%0.28
50DGTDIGICO INFRASTR REIT FPO/UNITS STAPLED4.45%0.17
51SFRSANDFIRE RESOURCES ORDINARY4.40%0.02
52TWETREASURY WINE ESTATE ORDINARY4.36%0.02
53LOVLOVISA HOLDINGS LTD ORDINARY4.35%0.02
54WHCWHITEHAVEN COAL ORDINARY4.33%0.28
55IDXINTEGRAL DIAGNOSTICS ORDINARY4.26%0.00
56ORAORORA LIMITED ORDINARY4.20%0.03
57JBHJB HI-FI LIMITED ORDINARY4.20%0.07
58LYCLYNAS RARE EARTHS ORDINARY4.17%0.96
59ZIPZIP CO LTD.. ORDINARY4.03%0.13
60PFPPROPEL FUNERAL ORDINARY4.02%0.15
61PMTPATRIOTBATTERYMETALS CDI 10:13.97%0.01
62MFGMAGELLAN FIN GRP LTD ORDINARY3.91%0.25
63CHNCHALICE MINING LTD ORDINARY3.91%0.02
64SOLSOUL PATTINSON (W.H) ORDINARY3.80%0.01
65APEEAGERS AUTOMOTIVE ORDINARY3.77%0.06
66BOTBOTANIX PHARMA LTD ORDINARY3.77%0.10
67REHREECE LIMITED ORDINARY3.68%0.14
68HCWHLTHCOHCWELLNSREIT ORDINARY UNITS3.60%0.34
69SDRSITEMINDER ORDINARY3.59%0.05
70MGHMAAS GROUP HOLDINGS ORDINARY3.46%0.01
71WBTWEEBIT NANO LTD ORDINARY3.37%0.29
72WDSWOODSIDE ENERGY ORDINARY3.33%0.05
73SYRSYRAH RESOURCES ORDINARY3.30%0.11
74BRNBRAINCHIP LTD ORDINARY3.30%0.12
75ARUARAFURA RARE EARTHS ORDINARY3.28%0.10
76APAAPA GROUP UNITS STAPLED3.25%0.08
77BPTBEACH ENERGY LIMITED ORDINARY3.23%0.19
78A2MTHE A2 MILK COMPANY ORDINARY3.22%0.37
79IMUIMUGENE LIMITED ORDINARY3.21%0.15
80KLSKELSIAN GROUP LTD ORDINARY3.21%0.23
81JLGJOHNS LYNG GROUP ORDINARY3.20%0.69
82SKCSKYCITY ENT GRP LTD ORD FOR. EXEMPT NZX3.19%0.00
83JHXJAMES HARDIE INDUST CHESS DEPOSITARY INT3.17%0.14
84ACLAU CLINICAL LABS ORDINARY3.14%0.04
85WGXWESTGOLD RESOURCES. ORDINARY3.14%0.04
86DRRDETERRA ORDINARY3.12%0.11
87RRLREGIS RESOURCES ORDINARY3.11%0.05
88SIGSIGMA HEALTH LTD ORDINARY3.09%0.08
89EMREMERALD RES NL ORDINARY3.05%0.03
90REAREA GROUP ORDINARY2.99%0.05
91NXLNUIX LIMITED ORDINARY2.93%0.09
92CRNCORONADO GLOBAL RES CDI 10:12.89%0.04
93NHCNEW HOPE CORPORATION ORDINARY2.85%0.18
94A4NALPHA HPA LTD ORDINARY2.81%0.02
95EDVENDEAVOUR ORDINARY2.78%0.19
96AOVAMOTIV ORDINARY2.77%0.00
97WEBWEB TRAVEL GROUP LTD ORDINARY2.69%0.01
98AGLAGL ENERGY LIMITED. ORDINARY2.69%0.03
99BAPBAPCOR LIMITED ORDINARY2.64%0.23
100CIPCENTURIA I REIT ORDINARY UNITS2.57%0.93
Data: 05/08/2025-12/08/2025
 
Heavily shorted stock. Was amonst the top 10 most shorted stock a week ago. Expect volitivity.

Top shorted stocks​

Data: 05/08/2025-12/08/2025
Expect volatility - noted ... jumps around a bit... up 7% today
 
Top